BD Starts Shipping First Smartphone-based Rapid COVID-19 Over-The-Counter Test

Becton, Dickinson & Company, a global med tech company also known as BD, announced today it has started shipping its COVID-19 rapid antigen test, a smartphone-based over-the-counter (OTC) test using inbuilt computer vision, and the first of its use this smartphone vision for interpreting test results. It is now available for purchase through the Amazon website.

COVID-19 testing has been made faster and easier with this new, rapid self-test from BD, which can be completed privately and safely at home.

BD Veritor home-based COVID-19 test results are displayed digitally as rapidly as 15 minutes after the test has been completed via the Scanwell® Health mobile app.

Additionally, it is the only at-home test that can completely automate results which report to public health agencies at the federal and state levels, as well as providing the simple means for optional reporting within business and education.

A manufacturer’s suggested retail price of $39.99 includes 2 tests in each box when purchased for home use, although the test will be available through at the reduced price of $26.50 over December exclusively to U.S. customers, as a result of a partnership with the U.S. government.

David Hickey, the president of Life Sciences for the company, said:

“Bringing the BD Veritor™ At-Home COVID-19 Test to enables U.S. consumers to purchase and perform an at-home COVID-19 test without leaving the comfort of their own home. Now that we are entering flu season, it is a perfect time to put a BD Veritor™ At-Home COVID-19 Test in your medicine cabinet, so if you or a family member develop flu-like symptoms — which can mirror COVID-19 symptoms — you can self-test for COVID-19 at home. In addition, The BD Veritor™ At-Home COVID-19 Test offers advantages over other at-home tests on the market, including smartphone interpretation and digital display of results, along with automated reporting. There is no guessing game about one line or two, as is sometimes the case with visually read tests. You get a definitive ‘POSITIVE’ or ‘NEGATIVE’ digital display of the result.”

Traditional Becton & Dickinson sales channels also offer the test to schools, businesses and governments aiming to facilitate self-testing for students or company employees.

Testing for COVID-19 at home can present several challenges, including unclear instructions, difficulty performing swabs, ambiguous results interpretation, and issues reporting results to school administrators and public health officials.

However here, digital “positive”/”negative” results are clearly displayed, while the BD Veritor™ At-Home COVID-19 Test also offers an easy-to-follow and intuitive mobile app containing step-by-step instructions, as well as a pain-free swab for nasal use, and negative results are automatically reported, meaning this test is likely to prove very popular in terms of sales.

© Becton, Dickinson & Company

Post a comment

Your email address will not be published. Required fields are marked *

Recent News

Successful completion of the inaugural shoulder arthroplasty surgeries utilizing Stryker’s Blueprint® Mixed Reality Guidance System occurred at Mayo Clinic in Minnesota and St. Joseph’s Health Care in London, Canada.

Medical Device Technologies Market is projected to increase from USD 4.20 Billion in 2022 to USD 16.32 Billion by 2030, reflecting a robust Compound Annual Growth Rate (CAGR) of 18.50% over the forecast period

Hodess Cleanroom Construction expands its cleanroom services capabilities with the acquisitions of Protocol Management Services and Clean Rooms West

Medtronic Will Invest Up to $75 Million And begin Co-Promotion For CathWorks’ FFRangio System In The U.S. Europe and Japan

Tornier Shoulder Arthroplasty Portfolio Introduced by Stryker, With New Tornier Perform Humeral System Launched in Europe